We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why it is Apt to Hold Hawaiian Holdings (HA) for Now
Read MoreHide Full Article
Hawaiian Holdings, Inc.’s (HA - Free Report) performance with respect to passenger revenues is encouraging. Notably, the company has raised guidance for first-quarter 2018 operating revenue per available seat mile (RASM) owing to better-than-expected passenger revenue performance in each of its geographies as well as higher cargo demand across the network. It now expects RASM to increase 3-5%, up from its previous prediction of a decline of 0.5% to a rise of 2.5%.
In 2017, passenger revenues increased 10.1% on a year-over-year basis, accounting for 87.6% of the company’s top line. The company’s growth is supported by strong demand for air travel to Hawaii. The exit of Island Air has further strengthened the airline’s foothold in the region.
The company’s decision announced in October 2017, to reward shareholders with dividend payments is also impressive. Later in December, the company announced a new share repurchase program worth $100 million through Dec 31, 2019, an addition to the existing $100 million authorization. Such investor-friendly initiatives bode well for the stock.
The airline’s efforts to modernize its fleet also raise optimism. To this end, it is on track to remodel its A330 fleet by adding lie flat premium seats.
The positive sentiment revolving around the stock is evident from the Zacks Consensus Estimate for current-quarter earnings being revised 39.6% upward in the last 60 days. While the same for the full year has moved 16.8% north.
Additionally, the company has an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum and the score is a weighted combination of all three scores.
In light of the above positives, we believe investors should hold on to Hawaiian Holdings stock for now.
Zacks Rank & Key Picks
Hawaiian Holdings carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same space are American Airlines Group Inc. (AAL - Free Report) , International Consolidated Airlines Group SA (ICAGY - Free Report) and AZUL SA (AZUL - Free Report) . While International Consolidated Airlines sports a Zacks Rank #1 (Strong Buy), American Airlines and AZUL carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of American Airlines, International Consolidated Airlines and AZUL have rallied more than 22%, 24% and 53%, respectively, in a year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Here's Why it is Apt to Hold Hawaiian Holdings (HA) for Now
Hawaiian Holdings, Inc.’s (HA - Free Report) performance with respect to passenger revenues is encouraging. Notably, the company has raised guidance for first-quarter 2018 operating revenue per available seat mile (RASM) owing to better-than-expected passenger revenue performance in each of its geographies as well as higher cargo demand across the network. It now expects RASM to increase 3-5%, up from its previous prediction of a decline of 0.5% to a rise of 2.5%.
In 2017, passenger revenues increased 10.1% on a year-over-year basis, accounting for 87.6% of the company’s top line. The company’s growth is supported by strong demand for air travel to Hawaii. The exit of Island Air has further strengthened the airline’s foothold in the region.
The company’s decision announced in October 2017, to reward shareholders with dividend payments is also impressive. Later in December, the company announced a new share repurchase program worth $100 million through Dec 31, 2019, an addition to the existing $100 million authorization. Such investor-friendly initiatives bode well for the stock.
The airline’s efforts to modernize its fleet also raise optimism. To this end, it is on track to remodel its A330 fleet by adding lie flat premium seats.
Hawaiian Holdings, Inc. Price and Consensus
Hawaiian Holdings, Inc. Price and Consensus | Hawaiian Holdings, Inc. Quote
The positive sentiment revolving around the stock is evident from the Zacks Consensus Estimate for current-quarter earnings being revised 39.6% upward in the last 60 days. While the same for the full year has moved 16.8% north.
Additionally, the company has an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum and the score is a weighted combination of all three scores.
In light of the above positives, we believe investors should hold on to Hawaiian Holdings stock for now.
Zacks Rank & Key Picks
Hawaiian Holdings carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same space are American Airlines Group Inc. (AAL - Free Report) , International Consolidated Airlines Group SA (ICAGY - Free Report) and AZUL SA (AZUL - Free Report) . While International Consolidated Airlines sports a Zacks Rank #1 (Strong Buy), American Airlines and AZUL carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of American Airlines, International Consolidated Airlines and AZUL have rallied more than 22%, 24% and 53%, respectively, in a year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>